2026. Safety and Efficacy of Tacrolimus Ointment 0.03 % as a Steroid-Sparing Regimen in Patients with Severe or Refractory Vernal Keratoconjunctivitis (VKC): A study from Quetta, Balochistan. Journal of Fatima Jinnah Medical University. 20, 2 (Aug. 2026), 99–104. DOI:https://doi.org/10.37018/ONBQ9330.